Obstructive sleep apnea and cardiometabolic risk

• Váldodahkkit: Vekić Jelena (Dahkki), Jelić-Ivanović Zorana (Dahkki), Zeljković Aleksandra (Dahkki), Stefanović Aleksandra (Dahkki), Spasojević-Kalimanovska Vesna (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Pharmaceutical Association of Serbia, Belgrade, Serbia, 2019-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Obstructive sleep apnea (OSA) is a chronic, progressive disorder with a high prevalence in the population. Without timely diagnosis and therapy OSA can significantly affect the quality of life of the patients. OSA is a common co-morbidity in patients with metabolic syndrome (MS) and cardiovascular d...